Acticor Biotech recruits first patient in Covid-19 related ARDS treatment trial,

Clinical stage biotechnology company Acticor Biotech has recruited the first patient in Phase II GARDEN study of glenzocimab (ACT017) to treat …, Clinical stage biotechnology company Acticor Biotech has recruited the first patient in Phase II GARDEN study of glenzocimab (ACT017) to treat …, Read More

Scroll to Top